Is PT-141 the same as bremelanotide?

Yes. PT-141 is the development code; bremelanotide is the INN; Vyleesi is the commercial brand.

What's the FDA-approved dose?

1.75 mg subcutaneous, taken at least 45 minutes before anticipated sexual activity, no more than once per 24 hours and no more than 8 doses per month.

PT-141 Calculator

Also known as: Bremelanotide, Vyleesi

Sexual

Default: 10mg / 2mL / 1.75mgAdjust inputs to match your vial

About

What is PT-141?

PT-141 (bremelanotide) is a melanocortin receptor agonist FDA-approved as Vyleesi for acquired hypoactive sexual desire disorder in premenopausal women at a 1.75 mg subcutaneous dose. Off-label use in men for erectile function is widespread but not FDA-approved.

Common vial sizes

5 mg	lyophilized powder
10 mg	lyophilized powder

Reference dose ranges

0.5 mg	≈ 10 U-100 units (at 10mg / 2mL)
1 mg	≈ 20 U-100 units (at 10mg / 2mL)
1.75 mg	≈ 35 U-100 units (at 10mg / 2mL)
2 mg	≈ 40 U-100 units (at 10mg / 2mL)

Reconstitution

How it's typically prepared

Reconstitute with BAC water; refrigerate.

FAQ

Frequently asked questions

Is PT-141 the same as bremelanotide?: Yes. PT-141 is the development code; bremelanotide is the INN; Vyleesi is the commercial brand.
What's the FDA-approved dose?: 1.75 mg subcutaneous, taken at least 45 minutes before anticipated sexual activity, no more than once per 24 hours and no more than 8 doses per month.

Sources

References

Other Sexual peptides

Notice

PeptideDose is an educational reference. It is not medical advice and does not replace consultation with a licensed healthcare provider. Doses shown in presets are derived from published protocols and product labels — they are not personal recommendations.